(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1318344 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ECT2 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1318345 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ECT2 mRNA CTD PMID:36331819 1,1-dichloroethene increases expression ISO RGD:1318345 6480464 vinylidene chloride results in increased expression of ECT2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine affects expression ISO RGD:1318345 6480464 1, 2-Dimethylhydrazine affects the expression of ECT2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ECT2 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1318344 6480464 Estradiol results in increased expression of ECT2 mRNA CTD PMID:16474171 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ECT2 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ECT2 mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1318345 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1318345 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318344 6480464 Tetrachlorodibenzodioxin affects the expression of ECT2 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ECT2 mRNA CTD PMID:32109520 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318345 6480464 Tetrachlorodibenzodioxin affects the expression of ECT2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1318344 6480464 Tetrachlorodibenzodioxin results in decreased expression of ECT2 mRNA CTD PMID:20106945 , PMID:21632981 2-butoxyethanol increases expression ISO RGD:1318345 6480464 n-butoxyethanol results in increased expression of ECT2 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:1318344 6480464 beta-methylcholine affects the expression of ECT2 mRNA CTD PMID:21179406 3-methylcholanthrene increases expression ISO RGD:1318345 6480464 Methylcholanthrene results in increased expression of ECT2 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ECT2 mRNA CTD PMID:25380136 5-fluorouracil multiple interactions ISO RGD:1318344 6480464 TP53 protein promotes the reaction [Fluorouracil results in decreased expression of ECT2 mRNA] CTD PMID:17982676 5-fluorouracil decreases expression ISO RGD:1318344 6480464 Fluorouracil results in decreased expression of ECT2 mRNA CTD PMID:17982676 acetamide increases expression EXP 6480464 acetamide results in increased expression of ECT2 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1318344 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ECT2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ECT2 mRNA CTD PMID:32699268 aflatoxin B1 affects expression ISO RGD:1318344 6480464 Aflatoxin B1 affects the expression of ECT2 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ECT2 mRNA CTD PMID:25378103 all-trans-retinoic acid decreases expression ISO RGD:1318344 6480464 Tretinoin results in decreased expression of ECT2 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1318344 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ECT2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ECT2 mRNA CTD PMID:32699268 aristolochic acid A decreases expression ISO RGD:1318344 6480464 aristolochic acid I results in decreased expression of ECT2 mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO RGD:1318345 6480464 arsenite results in decreased expression of ECT2 mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO RGD:1318344 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ECT2 mRNA] CTD PMID:32406909 benzene increases expression ISO RGD:1318345 6480464 Benzene results in increased expression of ECT2 mRNA CTD PMID:34624356 benzo[a]pyrene increases expression ISO RGD:1318345 6480464 Benzo(a)pyrene results in increased expression of ECT2 mRNA CTD PMID:20504355 , PMID:32417428 benzo[a]pyrene decreases expression ISO RGD:1318345 6480464 Benzo(a)pyrene results in decreased expression of ECT2 mRNA CTD PMID:19770486 , PMID:21569818 benzo[a]pyrene increases expression ISO RGD:1318344 6480464 Benzo(a)pyrene results in increased expression of ECT2 mRNA CTD PMID:20106945 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1318344 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1318345 6480464 benzo(b)fluoranthene results in increased expression of ECT2 mRNA CTD PMID:26377693 bisphenol A increases expression ISO RGD:1318344 6480464 bisphenol A results in increased expression of ECT2 mRNA CTD PMID:16474171 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ECT2 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO RGD:1318344 6480464 bisphenol A results in decreased expression of ECT2 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ECT2 mRNA CTD PMID:25181051 , PMID:26982218 buta-1,3-diene increases expression ISO RGD:1318345 6480464 1, 3-butadiene results in increased expression of ECT2 mRNA CTD PMID:29038090 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of ECT2 mRNA CTD PMID:25993096 caffeine decreases phosphorylation ISO RGD:1318344 6480464 Caffeine results in decreased phosphorylation of ECT2 protein CTD PMID:35688186 calcitriol multiple interactions ISO RGD:1318344 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ECT2 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1318344 6480464 Calcitriol results in decreased expression of ECT2 mRNA CTD PMID:21592394 cannabidiol increases expression ISO RGD:1318344 6480464 Cannabidiol results in increased expression of ECT2 mRNA CTD PMID:27918106 carbon nanotube increases expression ISO RGD:1318345 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1318345 6480464 Nanotubes, Carbon results in decreased expression of ECT2 mRNA CTD PMID:25620056 chloroprene increases expression ISO RGD:1318345 6480464 Chloroprene results in increased expression of ECT2 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:1318345 6480464 Chlorpyrifos results in decreased expression of ECT2 mRNA CTD PMID:37019170 cisplatin multiple interactions ISO RGD:1318344 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ECT2 mRNA, Cisplatin promotes the reaction [Piroxicam results in decreased expression of ECT2 mRNA] CTD PMID:21858171 , PMID:27392435 cisplatin decreases expression ISO RGD:1318344 6480464 Cisplatin results in decreased expression of ECT2 mRNA CTD PMID:27392435 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ECT2 mRNA CTD PMID:22023808 cobalt dichloride decreases expression ISO RGD:1318344 6480464 cobaltous chloride results in decreased expression of ECT2 mRNA CTD PMID:19320972 , PMID:19376846 copper atom increases expression EXP 6480464 Copper results in increased expression of ECT2 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of ECT2 mRNA CTD PMID:30556269 coumestrol multiple interactions ISO RGD:1318344 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1318344 6480464 Coumestrol results in increased expression of ECT2 mRNA CTD PMID:19167446 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ECT2 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1318344 6480464 Cyclosporine results in decreased expression of ECT2 mRNA CTD PMID:20106945 , PMID:21632981 cyclosporin A increases expression ISO RGD:1318344 6480464 Cyclosporine results in increased expression of ECT2 mRNA CTD PMID:25562108 deoxynivalenol increases expression ISO RGD:1318344 6480464 deoxynivalenol results in increased expression of ECT2 mRNA CTD PMID:31863870 dichloroacetic acid increases expression ISO RGD:1318345 6480464 Dichloroacetic Acid results in increased expression of ECT2 mRNA CTD PMID:28962523 diclofenac increases expression ISO RGD:1318345 6480464 Diclofenac results in increased expression of ECT2 mRNA CTD PMID:26934552 dicrotophos decreases expression ISO RGD:1318344 6480464 dicrotophos results in decreased expression of ECT2 mRNA CTD PMID:28302478 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of ECT2 mRNA CTD PMID:23153324 dorsomorphin multiple interactions ISO RGD:1318344 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECT2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1318344 6480464 Doxorubicin results in decreased expression of ECT2 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:1318344 6480464 ECT2 protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] CTD PMID:27106762 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ECT2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1318344 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ECT2 mRNA CTD PMID:19167446 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of ECT2 mRNA CTD PMID:24412560 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of ECT2 mRNA CTD PMID:24412560 folic acid decreases expression ISO RGD:1318345 6480464 Folic Acid results in decreased expression of ECT2 mRNA CTD PMID:25629700 furan increases expression ISO RGD:1318345 6480464 furan results in increased expression of ECT2 mRNA CTD PMID:24183702 furan increases expression EXP 6480464 furan results in increased expression of ECT2 mRNA CTD PMID:25539665 genistein increases expression ISO RGD:1318344 6480464 Genistein results in increased expression of ECT2 mRNA CTD PMID:16474171 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ECT2 mRNA CTD PMID:22061828 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of ECT2 mRNA CTD PMID:24395379 glycine betaine decreases expression EXP 6480464 Betaine results in decreased expression of ECT2 mRNA CTD PMID:26391144 heptachlor increases expression EXP 6480464 Heptachlor results in increased expression of ECT2 mRNA CTD PMID:23153324 hydrogen peroxide affects expression ISO RGD:1318344 6480464 Hydrogen Peroxide affects the expression of ECT2 mRNA CTD PMID:21179406 ivermectin decreases expression ISO RGD:1318344 6480464 Ivermectin results in decreased expression of ECT2 protein CTD PMID:32959892 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of ECT2 mRNA CTD PMID:20080153 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of ECT2 mRNA CTD PMID:35283115 lithium atom increases expression EXP 6480464 Lithium results in increased expression of ECT2 mRNA CTD PMID:21711903 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of ECT2 mRNA CTD PMID:21711903 lucanthone decreases expression ISO RGD:1318344 6480464 Lucanthone results in decreased expression of ECT2 mRNA CTD PMID:21148553 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of ECT2 mRNA CTD PMID:28341135 methylmercury chloride decreases expression ISO RGD:1318344 6480464 methylmercuric chloride results in decreased expression of ECT2 mRNA CTD PMID:34089799 mirex increases expression EXP 6480464 Mirex results in increased expression of ECT2 mRNA CTD PMID:23153324 N-nitrosodiethylamine increases expression ISO RGD:1318345 6480464 Diethylnitrosamine results in increased expression of ECT2 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1318345 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ECT2 mRNA, RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ECT2 mRNA] CTD PMID:17854601 , PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ECT2 mRNA CTD PMID:25380136 N-Nitrosopyrrolidine decreases expression ISO RGD:1318344 6480464 N-Nitrosopyrrolidine results in decreased expression of ECT2 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1318344 6480464 Nickel results in increased expression of ECT2 mRNA CTD PMID:25583101 ochratoxin A decreases acetylation ISO RGD:1318344 6480464 ochratoxin A results in decreased acetylation of ECT2 promoter CTD PMID:29098329 ochratoxin A multiple interactions ISO RGD:1318344 6480464 [ochratoxin A results in decreased acetylation of ECT2 promoter] which results in decreased expression of ECT2 mRNA CTD PMID:29098329 ochratoxin A decreases expression ISO RGD:1318344 6480464 ochratoxin A results in decreased expression of ECT2 mRNA CTD PMID:29098329 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of ECT2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ECT2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1318345 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ECT2 mRNA more ... CTD PMID:19555225 more ... ozone multiple interactions ISO RGD:1318344 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ECT2 mRNA more ... CTD PMID:32699268 ozone increases expression ISO RGD:1318345 6480464 Ozone results in increased expression of ECT2 mRNA CTD PMID:12763052 paracetamol affects expression ISO RGD:1318345 6480464 Acetaminophen affects the expression of ECT2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ECT2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1318344 6480464 Acetaminophen results in decreased expression of ECT2 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:1318344 6480464 Acetaminophen results in increased expression of ECT2 mRNA CTD PMID:22230336 PCB138 multiple interactions ISO RGD:1318345 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid decreases expression ISO RGD:1318344 6480464 perfluoro-n-nonanoic acid results in decreased expression of ECT2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1318344 6480464 perfluorooctane sulfonic acid results in decreased expression of ECT2 mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1318345 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ECT2 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:1318344 6480464 perfluorooctanoic acid results in decreased expression of ECT2 mRNA CTD PMID:36326898 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of ECT2 mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:1318345 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ECT2 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ECT2 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:1318345 6480464 Phenobarbital results in increased expression of ECT2 mRNA CTD PMID:19482888 more ... pirinixic acid multiple interactions ISO RGD:1318345 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of ECT2 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of ECT2 mRNA] CTD PMID:17950772 , PMID:20813756 pirinixic acid increases expression ISO RGD:1318345 6480464 pirinixic acid results in increased expression of ECT2 mRNA CTD PMID:17950772 more ... piroxicam decreases expression ISO RGD:1318344 6480464 Piroxicam results in decreased expression of ECT2 mRNA CTD PMID:21858171 piroxicam multiple interactions ISO RGD:1318344 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of ECT2 mRNA] CTD PMID:21858171 potassium chromate decreases expression ISO RGD:1318344 6480464 potassium chromate(VI) results in decreased expression of ECT2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1318344 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ECT2 mRNA CTD PMID:22079256 propiconazole increases expression ISO RGD:1318345 6480464 propiconazole results in increased expression of ECT2 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:1318344 6480464 Quercetin results in decreased expression of ECT2 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1318344 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of ECT2 mRNA CTD PMID:19167446 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ECT2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1318344 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECT2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1318344 6480464 Silicon Dioxide results in increased expression of ECT2 mRNA CTD PMID:25351596 silicon dioxide increases expression ISO RGD:1318345 6480464 Silicon Dioxide results in increased expression of ECT2 mRNA CTD PMID:29341224 sodium arsenite decreases expression ISO RGD:1318345 6480464 sodium arsenite results in decreased expression of ECT2 mRNA CTD PMID:17998272 sodium arsenite increases expression ISO RGD:1318344 6480464 sodium arsenite results in increased expression of ECT2 mRNA CTD PMID:29301061 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of ECT2 mRNA CTD PMID:22561333 sodium dichromate decreases expression ISO RGD:1318345 6480464 sodium bichromate results in decreased expression of ECT2 mRNA CTD PMID:31558096 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of ECT2 mRNA CTD PMID:22561333 Soman increases expression EXP 6480464 Soman results in increased expression of ECT2 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1318345 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ECT2 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1318344 6480464 Sunitinib results in decreased expression of ECT2 mRNA CTD PMID:31533062 tamoxifen decreases expression ISO RGD:1318345 6480464 Tamoxifen results in decreased expression of ECT2 mRNA CTD PMID:25123088 testosterone multiple interactions ISO RGD:1318344 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ECT2 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ECT2 mRNA CTD PMID:32741896 testosterone decreases expression ISO RGD:1318344 6480464 Testosterone results in decreased expression of ECT2 mRNA CTD PMID:21592394 testosterone enanthate affects expression ISO RGD:1318344 6480464 testosterone enanthate affects the expression of ECT2 mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:1318345 6480464 Carbon Tetrachloride results in increased expression of ECT2 mRNA CTD PMID:17484886 more ... thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ECT2 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide increases expression ISO RGD:1318345 6480464 titanium dioxide results in increased expression of ECT2 mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of ECT2 mRNA CTD PMID:30012374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ECT2 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of ECT2 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1318345 6480464 Trichloroethylene results in increased expression of ECT2 mRNA CTD PMID:25549359 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ECT2 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1318344 6480464 trichostatin A results in decreased expression of ECT2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1318344 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECT2 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:1318345 6480464 trimellitic anhydride results in increased expression of ECT2 mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:1318345 6480464 triptonide results in increased expression of ECT2 mRNA CTD PMID:33045310 trovafloxacin decreases expression ISO RGD:1318345 6480464 trovafloxacin results in decreased expression of ECT2 mRNA CTD PMID:35537566 valproic acid affects expression ISO RGD:1318345 6480464 Valproic Acid affects the expression of ECT2 mRNA CTD PMID:17292431 , PMID:17963808
